Luis F Callado
Overview
Explore the profile of Luis F Callado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
1550
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarries-Serrano U, Miquel-Rio L, Santana N, Paz V, Sancho-Alonso M, Callado L, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2025 Feb;
138:111299.
PMID: 40015617
Major depressive disorder (MDD) is characterized by significant impairment in social, emotional, and cognitive functioning. Its precise pathophysiology remains poorly understood. Alterations in protein homeostasis and some misfolded proteins have...
2.
Martinez-Peula O, Ramos-Miguel A, Muguruza C, Callado L, Meana J, Rivero G
J Neurosci Methods
. 2025 Jan;
416:110365.
PMID: 39832625
Background: Histone deacetylase (HDAC) density and activity are altered in different brain disorders. Antipsychotic drugs (APs) might modulate HDAC activity in brains of schizophrenia subjects. New Method: HDAC activity assay...
3.
Bagan A, Lopez-Ruiz A, Abas S, Ruiz-Cantero M, Vasilopoulou F, Taboada-Jara T, et al.
J Med Chem
. 2025 Jan;
68(3):2551-2573.
PMID: 39818939
Imidazoline receptors (I-IRs) are altered in Alzheimer's disease (AD) patients and are associated with analgesia. I-IRs are not structurally described, and their pharmacological characterization relies on their modulation by highly...
4.
Bagan A, Abas S, Pala-Pujadas J, Irisarri A, Grinan-Ferre C, Pallas M, et al.
Bioorg Chem
. 2024 Nov;
142:106935.
PMID: 39492364
Recent studies pointed out the modulation of imidazoline I receptors (I-IR) by selective ligands as a putative strategy to face neurodegenerative diseases. Foregoing the classical 2-imidazoline/imidazole-containing I-IR ligands, we report...
5.
Mudyanselage A, Wijamunige B, Kocon A, Turner R, McLean D, Morentin B, et al.
Antioxidants (Basel)
. 2024 May;
13(5).
PMID: 38790685
Alcohol is toxic to neurons and can trigger alcohol-related brain damage, neuronal loss, and cognitive decline. Neuronal cells may be vulnerable to alcohol toxicity and damage from oxidative stress after...
6.
Riga M, Perez-Fernandez M, Miquel-Rio L, Paz V, Campa L, Martinez-Losa M, et al.
Brain
. 2024 May;
147(12):4169-4184.
PMID: 38769595
Altered development and function of the prefrontal cortex (PFC) during adolescence is implicated in the origin of mental disorders. Deficits in the GABAergic system prominently contribute to these alterations. Nav1.1...
7.
Bulduk B, Tortajada J, Valiente-Palleja A, Callado L, Torrell H, Vilella E, et al.
Psychiatry Res
. 2024 May;
337:115928.
PMID: 38759415
Previous studies have shown mitochondrial dysfunction in schizophrenia (SZ) patients, which may be caused by mitochondrial DNA (mtDNA) alterations. However, there are few studies in SZ that have analyzed mtDNA...
8.
Almodovar-Paya C, Guardiola-Ripoll M, Giralt-Lopez M, Oscoz-Irurozqui M, Canales-Rodriguez E, Madre M, et al.
Brain Struct Funct
. 2024 May;
229(5):1299-1315.
PMID: 38720004
The expression of Neuritin-1 (NRN1), a neurotrophic factor crucial for neurodevelopment and synaptic plasticity, is enhanced by the Brain Derived Neurotrophic Factor (BDNF). Although the receptor of NRN1 remains unclear,...
9.
Zhu B, Ainsworth R, Wang Z, Liu Z, Sierra S, Deng C, et al.
Elife
. 2024 Apr;
12.
PMID: 38648100
Genome-wide association studies have revealed >270 loci associated with schizophrenia risk, yet these genetic factors do not seem to be sufficient to fully explain the molecular determinants behind this psychiatric...
10.
DelaCuesta-Barrutia J, Martinez-Peula O, Rivero G, Santas-Martin J, Munarriz-Cuezva E, Brocos-Mosquera I, et al.
Transl Psychiatry
. 2024 Feb;
14(1):113.
PMID: 38396013
Antipsychotic-induced low availability of group II metabotropic glutamate receptors (including mGluR and mGluR) in brains of schizophrenia patients may explain the limited efficacy of mGluR ligands in clinical trials. Studies...